AbbVie Inc. (NYSE:ABBV)

buy sell

UBS’s Big List of Quality Stocks to Buy Now

Needless to say, the destruction in the markets since the beginning of the fourth quarter has been painful. The solid firms on Wall Street are rolling up their sleeves and ...
Read Full Story »
Sprint USB device

Sprint Drops From the 5 Most Shorted NYSE Stocks

The five most shorted stocks on the New York Stock Exchange at the September 30 settlement date saw rising short interest during the two-week period. Sprint was the exception, with ...
Read Full Story »
NYSE-flag

AbbVie Joins the 5 Most Shorted NYSE Stocks

Overall, there was little movement among the most shorted stocks on the New York Stock Exchange between the August 29 and September 15 settlement dates, other than a surge in ...
Read Full Story »
Tax

Is Treasury Plan for Tax Inversion REALLY Trouble for Merger Stocks?

The U.S. Treasury has finally made its proposed effort to deal with the waves of corporate tax inversions that have created such a stir of late. The move is also ...
Read Full Story »
health care

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

For a variety of reasons, the cases of chronic hepatitis in the United States have surged dramatically over the past 20 years. Currently, it is estimated that more than 3.2 ...
Read Full Story »
Sprint USB device

Sprint Joins the 5 Most Shorted NYSE Stocks

Surges in short interest between the August 15 and August 29 settlement dates pushed Sprint into the top five and Kinder Morgan into the top 10 most shorted stocks on ...
Read Full Story »
180519466

Is Infinity Fully Valued Now, or Is More Upside Left?

Infinity Pharmaceuticals Inc. (NASDAQ: INFI) has seen its stock rise so much on a pact that you might just think it is a buyout. It turns out that the pact ...
Read Full Story »
Pills

Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

While technology has dominated as the leading sector in the S&P 500 this year, currently up more than 20%, investors may be surprised to learn that pharmaceuticals have shown solid ...
Read Full Story »
Pills

AbbVie Earnings Take Back Seat to Shire Merger

AbbVie Inc. (NYSE: ABBV) reported second-quarter 2014 results before markets opened Friday. The pharmaceutical research firm posted adjusted diluted earnings per share (EPS) of $0.82 on revenues of $4.93 billion. ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

Stocks were firm on Tuesday morning during a shortened week that actually will be full of economic reports. 24/7 Wall St. reviews dozens of analyst research reports each morning of ...
Read Full Story »
health care

Analyst Cancer and Biotech Stock Picks From ASCO

As the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty pharmaceutical companies making announcements and presenting clinical data. The biggest ...
Read Full Story »
down market

Why You Buy Big Pharma If the Market Crashes

Defensive sectors have done well this year, with utilities leading the way. One of the reasons is that despite the market hitting new all-time highs, there remains a wall of ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: eBay, GNC, Groupon, Hecla, J.C. Penney, Whole Foods and More

Stocks are trying to recover on Wednesday after pulling back close to 2% from the recent highs. Investors still want bull market upside, but they want to avoid the blowups ...
Read Full Story »
Target logo

Why Target Shares Fell Rather Than Rose on CEO Firing

Shares of Target Corp. (NYSE: TGT) are taking a hit of around 3% Monday morning following the resignation/firing of Chairman/President/CEO Gregg Steinhafel. The now-former CEO is being replaced temporarily by ...
Read Full Story »
Merger

Baxter Split-Up, a Page From Abbott’s Playbook

Baxter International Inc. (NYSE: BAX) is taking an activist investor role of its own. The health care company has announced that it is splitting itself into two separate companies, in ...
Read Full Story »